'Proteolytic switching': Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 504-512

  MacDougall, J R ^a,b,d   Bani, M R ^a   Lin, Y ^a   Muschel, R J ^c   Kerbel, R S ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Northwestern Ontario Regional Cancer Centre   (Canada)

Author keywords

Cytokines; Gelatinase B; Melanoma; TIMP 1; Tumour progression

Indexed keywords

AZACITIDINE; CYTOKINE; GELATINASE B; INTERLEUKIN 1BETA; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0032927440     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690385     Document Type: Article

References (62)

1. Basset P, Belloq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajeer OL, Chenard MP, Rio MC and Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704
2. Bernhard EJ, Gruber SB and Muschel RJ (1994) Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/ collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Nat Acad Sci USA 91: 4293-4297
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyst Biochem 72: 248-254
4. Canete-Soler R, Litzky L, Lubensky I and Muschel RJ (1994) Localization of the 92 kD gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hyhridization. Am J Pathol 144: 518-527
5. Canete-Soler R, Gui YH, Linask KK and Muschel RJ (1995) MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Brain Res 88: 37-52
6. Chambers AF and Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Nat Cancer Inst 89: 1260-1270
7. Chenard MP, Osiorain L, Shering S, Rouyer N, Lutz Y, Wolf C, Basset P, Bellocq JP and Duffy MJ (1996) High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. Int J Cancer 69: 448-451
8. Chirivi RGS, Garofalo A, Crimmin MJ, Bawden LJ. Stoppacciaro A, Brown PD and Giavazzi R (1994) Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 58: 460-464
9. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 162: 156-159
10. Clark WH, Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D, Synnestvedt M and Halpern AC (1989) Model predicting survival in stage I melanoma based on tumor progression. J Nat Cancer Inst 81: 1983-1904
11. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA and Goldberg GI (1988) H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 263: 6579-6587
12. Cornil I, Man S, Fernandez B and Kerbel RS (1989) Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. J Natl Cancer Inst 81: 938-944
13. DeClerck YA and Imren S (1994) Protease inhibitors: role and potential therapeutic use in human cancer. Eur J Cancer 30A: 2170-2180
14. DeClerck YA, Yean T-D, Chan D, Shimada H and Langley KE (1991) Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 51: 2151-2157
15. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE and Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701-708
16. d'Ortho MP, Stanton H, Butler M, Atkinson SJ, Murphy G and Hembry RM (1998) MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett 421: 159-164
17. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angle P and Heath JK (1987) Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899-1904
18. Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K and Nagase H (1995) Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 6: 255-263
19. Frisch SM, Reich R, Collier IE, Genrich LT, Martin G and Goldberg GI (1990) Adenovirus EIA represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene 5: 75-83
20. Herron GS, Banda MJ, Clark EJ, Gavrilovic J and Werb Z (1986) Secretion of metalloproteinases by stimulated capillary endothelial cells. 261: 2814-2818
21. Himelstein BP, Lee EJ, Sato H, Seiki M and Muschel RJ (1997) Transcriptional activation of the matrix metalloproteinase 9 gene in an h-ras and v-myc transformed rat embryo cell line. Oncogene 14: 1995-1998
22. Hua J and Muschel RJ (1996) Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 56: 5279-5284
23. Ito A, Sato T, Iga T and Mori Y (1990) Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett 269: 93-95
24. Kath R, Rodeck U, Parmiter A and Herlyn M (1991) Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions. Cancer Therapy Control 1: 179-191
25. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G and Denhardt DT (1989) Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243: 947-950
26. Khokha R, Zimmer MJ, Graham CH, Lala PK and Waterhouse P (1992) Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Nat Cancer Inst 84: 1017-1022
27. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL. Chambers AF and Groom, AC (1994) Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54: 4791-4797
28. Leco KJ, Apte SS, Taniguchi GT, Hawkes SP, Khokha R, Schultz GA and Edwards DR (1997) Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissue. FEBS Lett 401: 213-217
29. Levi E. Fridman R, Miao HQ. Ma YS, Yayon A and Vlodavsky I (1996) Matrix matalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor I. Proc Natl Acad Science USA 93: 7069-7074
30. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH and Fisher SJ (1991) 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 113: 437-449
31. Liotta LA and Stetler-Stevenson WG (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s
32. Lu C and Kerbel RS (1993) Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 120: 1281-1288
33. Lu C, Rak JW, Kobayashi H and Kerbel RS (1993) Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res 53. 2708-2711
34. MacDougall JR and Kerbel RS (1993) Responsiveness of normal/dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-β. Mol Cell Diff 1: 21-40
35. MacDougall JR and Matrisian LM (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362
36. MacDougall JR, Bani MR, Lin Y, Rak J and Kerbel RS (1995) The 92 kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55: 4174-4181
37. Manes S, Mira E, Barbacid MM, Cipres A, Fernandez-Resa P, Buesa JM, Merida I, Aracil, M. Marquez G and Martinez AC (1997) Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 272: 25706-25712
38. Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53: 288-295
39. r 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 50: 6162-6170
40. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB and Deuel TF (1987) Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237: 1333-1336
41. Onisto M, Garbisa S, Caenazzo C, Freda MP, DiFrancesco C, Nitti D, Liotta LA and Stetler-Stevenson WG (1994) Reverse transcription-polymerase chain reaction phenotyping of metalloproteinase and inhibitors involved in tumor matrix invasion. Diagn Mol Pathol 2: 74-80
42. Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB and Bowden GT (1993) Expression of the metalloproteinase matrilysin in Du-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 53: 417-422
43. r 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52: 1336-1341
44. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL and Sawaya RE (1996) Expression and localization of 92 kDa type IV collagenase gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis 14: 12-18
45. Ronan SG, Eng AM, Briele HA, Shioura NN and Das Gupta TK (1987) Thin malignant melanomas with regression and metastases. Arch Dermatol 123: 1326-1330
46. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H and Larjava H (1991) Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266: 11436-11441
47. Sato H and Seiki M (1993) Regulatory mechanisms of 92 kDA type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405
48. Sehgal G, Hua J, Bernhard EJ, Sehgal I, Thompson TC and Muschel RJ (1998) Requirement for matrix metalloproteinase 9 (gelatinase B) expression in metastasis by murine prostate carcinoma. Am J Pathol 152: 591-596
49. Soini Y, Hurskainen T, Hoyhtya M, Oikarinen A and Autio-Harmainen H (1994) 72 kD and 92 kD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem 42: 945-951
50. Stetler-Stevenson WG, Liotta LA and Kleiner DE (1993) Extracellular matrix 6: ole of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434-1441
51. Stetler-Stevenson WG, Hewitt R and Corcoran M (1996) Matrix metalloproteinases and tumor invasion - from correlation and causality to the clinic. Semin Cancer Biol 7: 147-154
52. Suzuki M, Raab G, Moses MA, Fernandez CA and Klagsbrun M (1997) Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 272: 31730-31737
53. Ueda Y, Imai K, Tsuchiya H, Fujimoto N, Nakanishi I, Katsuda S, Seiki M and Okada Y (1996) Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. American J Pathol 148: 611-622
54. Unemori EN, Hibbs MS and Amento EP (1991) Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88: 1656-1662
55. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM and Werb Z (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422
56. Wang X, Fu X, Brown PD. Crimmin MJ and Hoffman RM (1994) Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54: 4726-4728
57. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T and Okada Y (1993) Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104: 991-999
58. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA and Goldberg GI (1989) SV-40 transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264: 17213-17221
59. Will H, Atkinson SJ, Butler GS, Smith B and Murphy G (1996) The soluble catalytic domain of membrane type I matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271: 17119-17123
60. Wilson CL, Heppner KJ, Labosky PA, Hogan BLM and Matrisian LM (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94: 1402-1407
61. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ and Matrisían LM (1994) Modulation of matryilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 54: 4805-4812
62. Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A and Matrisian LM (1994) A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinogen 10: 207-215